RxDoctor Payments Data

Sheeba Mesghali Morales, MD

Pediatrics · Venice, FLNPI 1336362706

Payments from drug & device makers

$18,148in general payments, 2019–2025

Across 949 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • Amgen$1K
  • AstraZeneca$1K
  • Pfizer$1K
  • GSK$912
  • plus $9K from 54 others

What the payments were for

  • Travel & lodging$410%
  • Food & beverage$17,93999%
  • Education$1681%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)167$3,066
Novo Nordisk76$1,518
Amgen81$1,421
AstraZeneca56$1,348
Pfizer63$1,074
GSK48$912
Boehringer Ingelheim40$756
Lilly USA, LLC37$620
Johnson & Johnson17$495
Takeda Pharmaceuticals U.S.A., Inc.27$485
Merck30$441
Bayer24$413
Radius Health, Inc.23$382
Biohaven Pharmaceuticals, Inc.17$358
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$327
Biohaven Pharmaceutical Holding Company Ltd.14$325
Exact Sciences10$282
Currax Pharmaceuticals LLC20$282
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$271
Dexcom, Inc.12$262
Astellas Pharma US Inc9$254
Amarin Pharma, Inc.12$231
Novartis12$224
Sanofi-aventis U.S. LLC13$217
Kowa Pharmaceuticals America, Inc.10$201
Boston Scientific6$171
Corium, LLC6$116
Abbott5$114
Assertio Therapeutics, Inc.6$113
Collegium Pharmaceutical, Inc.6$106
Almatica Pharma LLC7$105
Tris Pharma Inc4$88
Eisai Inc.4$70
Supernus Pharmaceuticals, Inc.4$62
Ironshore Pharmaceuticals Inc.3$60
Regeneron Healthcare Solutions, Inc.3$57
Shire North American Group Inc3$55
Cleerly, Inc.3$51
Alk-abello, Inc3$49
Paratek Pharmaceuticals, Inc.3$48
Vivus LLC3$46
Idorsia Pharmaceuticals US Inc2$42
Genentech USA, Inc.3$42
AMAG Pharmaceuticals, Inc.2$39
Centinel Spine, LLC1$39
Avanir Pharmaceuticals, Inc.2$37
Duchesnay USA Incorporated2$35
Exeltis, USA Inc.2$33
Teva Pharmaceuticals USA, Inc.2$31
E.r. Squibb & Sons, L.L.C.2$31
Phathom Pharmaceuticals, Inc.2$29
Axsome Therapeutics, Inc.1$26
Insulet Corporation1$25
Melinta Therapeutics, LLC2$24
Therapeuticsmd, Inc.1$23
Verrica Pharmaceuticals Inc.1$23
Mylan Specialty L.p.1$22
Irhythm Technologies, Inc.1$22
Baxter Healthcare1$21
Phadia US Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,148 in reported general payments places this provider in the 95th percentile of 3,964 pediatrics providers in Florida.

See all pediatrics providers in Florida

Medicare billing

Part B allowed, 2024
$210,273
Medicare patients
319
Services billed
3,791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide56$68,687
JardianceEmpagliflozin64$65,441
FarxigaDapagliflozin Propanediol48$62,312
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$54,451
OzempicSemaglutide37$47,347
XareltoRivaroxaban30$34,726
EliquisApixaban31$33,693
ProliaDenosumab14$24,775
MyrbetriqMirabegron16$19,822
Breo ElliptaFluticasone/Vilanterol42$18,988
Aimovig AutoinjectorErenumab-Aooe23$17,532
EntrestoSacubitril/Valsartan23$15,835
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$14,856
TrintellixVortioxetine Hydrobromide18$13,271
TrulicityDulaglutide12$12,549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$620$81,23768 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,348$77,16866 claims
GSKTrelegy Ellipta, Breo Ellipta$912$73,43981 claims
Boehringer IngelheimJardiance$756$65,44164 claims
Novo NordiskOzempic$1,518$47,34737 claims
Johnson & JohnsonXarelto$495$34,72630 claims
PfizerEliquis$1,074$33,69331 claims
AmgenProlia$1,421$24,77514 claims
Astellas Pharma US IncMyrbetriq$254$19,82216 claims
NovartisEntresto$224$15,83523 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$485$13,27118 claims
AbbVieSynthroid$3,066$7,33873 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,964 pediatrics providers in Florida.

Other pediatrics in Venice

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →